However, after stratifying the analysis based on the number of COVID-19 vaccinations, the SARM1 level was different in group A between the HP, T2DM, and T2DMN participants, while there was no difference in group B; see Figure 1 (Table 1, Table 2 and Table 3). This evidence concerns the gene SARM1 and type 2 diabetes mellitus.